PRGB

Protea Biosciences Group Inc

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 5/01/2017
Contact Info
  • 1311 Pineview Drive
  • Suite 501
  • Morgantown, WV 26505

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001335103
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2005
Employees 27 a/o Nov 01, 2016
Company Officers/Contacts
Stephen Turner CEO
David Halverson President
Cynthia Price Secretary
Matthew Powell CSO
Haddon Goodman CBO
Company Directors
Stephen Turner Chairman
Steven Antoline
Josiah Austin
Leonard Harris
Roderick Jackson
Ed Roberson
Scott Segal
Service Providers
Accounting/Auditing Firm
Schneider Downs & Co., Inc.
One PP Place
Suite 1700
Suite 1700, PA, 15222
United States

Legal Counsel
CKR Law LLP
1330 Avenue of the Americas
35th Floor
New York, NY, 10019
United States

Investor Relations Firm
Not Available
PRGB Security Details
Share Structure
Market Value1 $16,068,998 a/o Sep 25, 2017
Authorized Shares 750,000,000 a/o Sep 21, 2017
Outstanding Shares 401,724,947 a/o Sep 21, 2017
-Restricted 363,228,909 a/o Sep 21, 2017
-Unrestricted 38,496,038 a/o Sep 21, 2017
Held at DTC 32,403,020 a/o Sep 21, 2017
Float 20,679,540 a/o Mar 22, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders
Shareholders of Record 574 a/o Apr 14, 2017
Short Selling Data
Short Interest 9,900 (11.42%)
Aug 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security